Report Detail
Global Opioids Agonist Drugs Market Insights and Forecast to 2026
- RnM4114780 |
- 05 August, 2020 |
- Global |
- 119 Pages |
- QYResearch |
- Pharma & Healthcare
Opioids Agonist Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Opioids Agonist Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Opioids Agonist Drugs market is segmented into
Codeine
Fentanyl
Meperidine
Methadone
Morphine
Hydrocodone
Segment by Application, the Opioids Agonist Drugs market is segmented into
Pain Management
Cough Treatment
Diarrhea Treatment
Regional and Country-level Analysis
The Opioids Agonist Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Opioids Agonist Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Opioids Agonist Drugs Market Share Analysis
Opioids Agonist Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Opioids Agonist Drugs business, the date to enter into the Opioids Agonist Drugs market, Opioids Agonist Drugs product introduction, recent developments, etc.
The major vendors covered:
Purdue Pharma
Titan pharmaceuticals
Boehringer Ingelheim
Janssen Pharmaceuticals, Inc
Sanofi
Sun Pharmaceuticals
Mallinckrodt Pharmaceuticals
Egalet Corporation
Endo Pharmaceuticals Inc.
Allergan, Plc
Pfizer Inc
1 Study Coverage
- 1.1 Opioids Agonist Drugs Product Introduction
- 1.2 Market Segments
- 1.3 Key Opioids Agonist Drugs Manufacturers Covered: Ranking by Revenue
- 1.4 Market by Type
- 1.4.1 Global Opioids Agonist Drugs Market Size Growth Rate by Type
- 1.4.2 Codeine
- 1.4.3 Fentanyl
- 1.4.4 Meperidine
- 1.4.5 Methadone
- 1.4.6 Morphine
- 1.4.7 Hydrocodone
- 1.5 Market by Application
- 1.5.1 Global Opioids Agonist Drugs Market Size Growth Rate by Application
- 1.5.2 Pain Management
- 1.5.3 Cough Treatment
- 1.5.4 Diarrhea Treatment
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Opioids Agonist Drugs Market Size, Estimates and Forecasts
- 2.1.1 Global Opioids Agonist Drugs Revenue 2015-2026
- 2.1.2 Global Opioids Agonist Drugs Sales 2015-2026
- 2.2 Global Opioids Agonist Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
- 2.2.1 Global Opioids Agonist Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.2.2 Global Opioids Agonist Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Opioids Agonist Drugs Competitor Landscape by Players
- 3.1 Opioids Agonist Drugs Sales by Manufacturers
- 3.1.1 Opioids Agonist Drugs Sales by Manufacturers (2015-2020)
- 3.1.2 Opioids Agonist Drugs Sales Market Share by Manufacturers (2015-2020)
- 3.2 Opioids Agonist Drugs Revenue by Manufacturers
- 3.2.1 Opioids Agonist Drugs Revenue by Manufacturers (2015-2020)
- 3.2.2 Opioids Agonist Drugs Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global Opioids Agonist Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by Opioids Agonist Drugs Revenue in 2019
- 3.2.5 Global Opioids Agonist Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Opioids Agonist Drugs Price by Manufacturers
- 3.4 Opioids Agonist Drugs Manufacturing Base Distribution, Product Types
- 3.4.1 Opioids Agonist Drugs Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Opioids Agonist Drugs Product Type
- 3.4.3 Date of International Manufacturers Enter into Opioids Agonist Drugs Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
- 4.1 Global Opioids Agonist Drugs Market Size by Type (2015-2020)
- 4.1.1 Global Opioids Agonist Drugs Sales by Type (2015-2020)
- 4.1.2 Global Opioids Agonist Drugs Revenue by Type (2015-2020)
- 4.1.3 Opioids Agonist Drugs Average Selling Price (ASP) by Type (2015-2026)
- 4.2 Global Opioids Agonist Drugs Market Size Forecast by Type (2021-2026)
- 4.2.1 Global Opioids Agonist Drugs Sales Forecast by Type (2021-2026)
- 4.2.2 Global Opioids Agonist Drugs Revenue Forecast by Type (2021-2026)
- 4.2.3 Opioids Agonist Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
- 4.3 Global Opioids Agonist Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
- 5.1 Global Opioids Agonist Drugs Market Size by Application (2015-2020)
- 5.1.1 Global Opioids Agonist Drugs Sales by Application (2015-2020)
- 5.1.2 Global Opioids Agonist Drugs Revenue by Application (2015-2020)
- 5.1.3 Opioids Agonist Drugs Price by Application (2015-2020)
- 5.2 Opioids Agonist Drugs Market Size Forecast by Application (2021-2026)
- 5.2.1 Global Opioids Agonist Drugs Sales Forecast by Application (2021-2026)
- 5.2.2 Global Opioids Agonist Drugs Revenue Forecast by Application (2021-2026)
- 5.2.3 Global Opioids Agonist Drugs Price Forecast by Application (2021-2026)
6 North America
- 6.1 North America Opioids Agonist Drugs by Country
- 6.1.1 North America Opioids Agonist Drugs Sales by Country
- 6.1.2 North America Opioids Agonist Drugs Revenue by Country
- 6.1.3 U.S.
- 6.1.4 Canada
- 6.2 North America Opioids Agonist Drugs Market Facts & Figures by Type
- 6.3 North America Opioids Agonist Drugs Market Facts & Figures by Application
7 Europe
- 7.1 Europe Opioids Agonist Drugs by Country
- 7.1.1 Europe Opioids Agonist Drugs Sales by Country
- 7.1.2 Europe Opioids Agonist Drugs Revenue by Country
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 U.K.
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Opioids Agonist Drugs Market Facts & Figures by Type
- 7.3 Europe Opioids Agonist Drugs Market Facts & Figures by Application
8 Asia Pacific
- 8.1 Asia Pacific Opioids Agonist Drugs by Region
- 8.1.1 Asia Pacific Opioids Agonist Drugs Sales by Region
- 8.1.2 Asia Pacific Opioids Agonist Drugs Revenue by Region
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 South Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Taiwan
- 8.1.9 Indonesia
- 8.1.10 Thailand
- 8.1.11 Malaysia
- 8.1.12 Philippines
- 8.1.13 Vietnam
- 8.2 Asia Pacific Opioids Agonist Drugs Market Facts & Figures by Type
- 8.3 Asia Pacific Opioids Agonist Drugs Market Facts & Figures by Application
9 Latin America
- 9.1 Latin America Opioids Agonist Drugs by Country
- 9.1.1 Latin America Opioids Agonist Drugs Sales by Country
- 9.1.2 Latin America Opioids Agonist Drugs Revenue by Country
- 9.1.3 Mexico
- 9.1.4 Brazil
- 9.1.5 Argentina
- 9.2 Central & South America Opioids Agonist Drugs Market Facts & Figures by Type
- 9.3 Central & South America Opioids Agonist Drugs Market Facts & Figures by Application
10 Middle East and Africa
- 10.1 Middle East and Africa Opioids Agonist Drugs by Country
- 10.1.1 Middle East and Africa Opioids Agonist Drugs Sales by Country
- 10.1.2 Middle East and Africa Opioids Agonist Drugs Revenue by Country
- 10.1.3 Turkey
- 10.1.4 Saudi Arabia
- 10.1.5 U.A.E
- 10.2 Middle East and Africa Opioids Agonist Drugs Market Facts & Figures by Type
- 10.3 Middle East and Africa Opioids Agonist Drugs Market Facts & Figures by Application
11 Company Profiles
- 11.1 Purdue Pharma
- 11.1.1 Purdue Pharma Corporation Information
- 11.1.2 Purdue Pharma Description and Business Overview
- 11.1.3 Purdue Pharma Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Purdue Pharma Opioids Agonist Drugs Products Offered
- 11.1.5 Purdue Pharma Related Developments
- 11.2 Titan pharmaceuticals
- 11.2.1 Titan pharmaceuticals Corporation Information
- 11.2.2 Titan pharmaceuticals Description and Business Overview
- 11.2.3 Titan pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
- 11.2.4 Titan pharmaceuticals Opioids Agonist Drugs Products Offered
- 11.2.5 Titan pharmaceuticals Related Developments
- 11.3 Boehringer Ingelheim
- 11.3.1 Boehringer Ingelheim Corporation Information
- 11.3.2 Boehringer Ingelheim Description and Business Overview
- 11.3.3 Boehringer Ingelheim Sales, Revenue and Gross Margin (2015-2020)
- 11.3.4 Boehringer Ingelheim Opioids Agonist Drugs Products Offered
- 11.3.5 Boehringer Ingelheim Related Developments
- 11.4 Janssen Pharmaceuticals, Inc
- 11.4.1 Janssen Pharmaceuticals, Inc Corporation Information
- 11.4.2 Janssen Pharmaceuticals, Inc Description and Business Overview
- 11.4.3 Janssen Pharmaceuticals, Inc Sales, Revenue and Gross Margin (2015-2020)
- 11.4.4 Janssen Pharmaceuticals, Inc Opioids Agonist Drugs Products Offered
- 11.4.5 Janssen Pharmaceuticals, Inc Related Developments
- 11.5 Sanofi
- 11.5.1 Sanofi Corporation Information
- 11.5.2 Sanofi Description and Business Overview
- 11.5.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
- 11.5.4 Sanofi Opioids Agonist Drugs Products Offered
- 11.5.5 Sanofi Related Developments
- 11.6 Sun Pharmaceuticals
- 11.6.1 Sun Pharmaceuticals Corporation Information
- 11.6.2 Sun Pharmaceuticals Description and Business Overview
- 11.6.3 Sun Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
- 11.6.4 Sun Pharmaceuticals Opioids Agonist Drugs Products Offered
- 11.6.5 Sun Pharmaceuticals Related Developments
- 11.7 Mallinckrodt Pharmaceuticals
- 11.7.1 Mallinckrodt Pharmaceuticals Corporation Information
- 11.7.2 Mallinckrodt Pharmaceuticals Description and Business Overview
- 11.7.3 Mallinckrodt Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
- 11.7.4 Mallinckrodt Pharmaceuticals Opioids Agonist Drugs Products Offered
- 11.7.5 Mallinckrodt Pharmaceuticals Related Developments
- 11.8 Egalet Corporation
- 11.8.1 Egalet Corporation Corporation Information
- 11.8.2 Egalet Corporation Description and Business Overview
- 11.8.3 Egalet Corporation Sales, Revenue and Gross Margin (2015-2020)
- 11.8.4 Egalet Corporation Opioids Agonist Drugs Products Offered
- 11.8.5 Egalet Corporation Related Developments
- 11.9 Endo Pharmaceuticals Inc.
- 11.9.1 Endo Pharmaceuticals Inc. Corporation Information
- 11.9.2 Endo Pharmaceuticals Inc. Description and Business Overview
- 11.9.3 Endo Pharmaceuticals Inc. Sales, Revenue and Gross Margin (2015-2020)
- 11.9.4 Endo Pharmaceuticals Inc. Opioids Agonist Drugs Products Offered
- 11.9.5 Endo Pharmaceuticals Inc. Related Developments
- 11.10 Allergan, Plc
- 11.10.1 Allergan, Plc Corporation Information
- 11.10.2 Allergan, Plc Description and Business Overview
- 11.10.3 Allergan, Plc Sales, Revenue and Gross Margin (2015-2020)
- 11.10.4 Allergan, Plc Opioids Agonist Drugs Products Offered
- 11.10.5 Allergan, Plc Related Developments
- 11.1 Purdue Pharma
- 11.1.1 Purdue Pharma Corporation Information
- 11.1.2 Purdue Pharma Description and Business Overview
- 11.1.3 Purdue Pharma Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Purdue Pharma Opioids Agonist Drugs Products Offered
- 11.1.5 Purdue Pharma Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
- 12.1 Opioids Agonist Drugs Market Estimates and Projections by Region
- 12.1.1 Global Opioids Agonist Drugs Sales Forecast by Regions 2021-2026
- 12.1.2 Global Opioids Agonist Drugs Revenue Forecast by Regions 2021-2026
- 12.2 North America Opioids Agonist Drugs Market Size Forecast (2021-2026)
- 12.2.1 North America: Opioids Agonist Drugs Sales Forecast (2021-2026)
- 12.2.2 North America: Opioids Agonist Drugs Revenue Forecast (2021-2026)
- 12.2.3 North America: Opioids Agonist Drugs Market Size Forecast by Country (2021-2026)
- 12.3 Europe Opioids Agonist Drugs Market Size Forecast (2021-2026)
- 12.3.1 Europe: Opioids Agonist Drugs Sales Forecast (2021-2026)
- 12.3.2 Europe: Opioids Agonist Drugs Revenue Forecast (2021-2026)
- 12.3.3 Europe: Opioids Agonist Drugs Market Size Forecast by Country (2021-2026)
- 12.4 Asia Pacific Opioids Agonist Drugs Market Size Forecast (2021-2026)
- 12.4.1 Asia Pacific: Opioids Agonist Drugs Sales Forecast (2021-2026)
- 12.4.2 Asia Pacific: Opioids Agonist Drugs Revenue Forecast (2021-2026)
- 12.4.3 Asia Pacific: Opioids Agonist Drugs Market Size Forecast by Region (2021-2026)
- 12.5 Latin America Opioids Agonist Drugs Market Size Forecast (2021-2026)
- 12.5.1 Latin America: Opioids Agonist Drugs Sales Forecast (2021-2026)
- 12.5.2 Latin America: Opioids Agonist Drugs Revenue Forecast (2021-2026)
- 12.5.3 Latin America: Opioids Agonist Drugs Market Size Forecast by Country (2021-2026)
- 12.6 Middle East and Africa Opioids Agonist Drugs Market Size Forecast (2021-2026)
- 12.6.1 Middle East and Africa: Opioids Agonist Drugs Sales Forecast (2021-2026)
- 12.6.2 Middle East and Africa: Opioids Agonist Drugs Revenue Forecast (2021-2026)
- 12.6.3 Middle East and Africa: Opioids Agonist Drugs Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter's Five Forces Analysis
- 13.5 Primary Interviews with Key Opioids Agonist Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Opioids Agonist Drugs Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Opioids Agonist Drugs. Industry analysis & Market Report on Opioids Agonist Drugs is a syndicated market report, published as Global Opioids Agonist Drugs Market Insights and Forecast to 2026. It is complete Research Study and Industry Analysis of Opioids Agonist Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
